- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: D isomer.
Displaying page 1 of 1.
EudraCT Number: 2005-002421-31 | Sponsor Protocol Number: P-AD452-022 | Start Date*: 2005-09-16 | |||||||||||
Sponsor Name:Arakis Ltd | |||||||||||||
Full Title: A phase II randomized, double-blind, multicentre, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of 3 strengths of AD 452 in adult subjects ... | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002762-38 | Sponsor Protocol Number: Clin-AGI001-001 | Start Date*: 2005-04-13 | |||||||||||
Sponsor Name:AGI Therapeutics Limited | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled study of AGI 001 in the treatment of functional dyspepsia | |||||||||||||
Medical condition: Functional (Non-ulcer) Dyspepsia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007555-14 | Sponsor Protocol Number: C10953/2032/DP/US | Start Date*: 2008-08-15 | |||||||||||
Sponsor Name:Cephalon, Inc. | |||||||||||||
Full Title: An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive Therapy in Adults With Major ... | |||||||||||||
Medical condition: Major Depression Associated With Bipolar I Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003901-23 | Sponsor Protocol Number: K-001-201 | Start Date*: 2022-05-11 | |||||||||||
Sponsor Name:Kowa Research Institute, Inc | |||||||||||||
Full Title: A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic N... | |||||||||||||
Medical condition: Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) BG (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
